175 related articles for article (PubMed ID: 25250825)
1. Selenorhodamine photosensitizers for photodynamic therapy of P-glycoprotein-expressing cancer cells.
Hill JE; Linder MK; Davies KS; Sawada GA; Morgan J; Ohulchanskyy TY; Detty MR
J Med Chem; 2014 Oct; 57(20):8622-34. PubMed ID: 25250825
[TBL] [Abstract][Full Text] [Related]
2. Selenorhodamine photosensitizers with the Texas-red core for photodynamic therapy of cancer cells.
Kryman MW; Davies KS; Linder MK; Ohulchanskyy TY; Detty MR
Bioorg Med Chem; 2015 Aug; 23(15):4501-4507. PubMed ID: 26105712
[TBL] [Abstract][Full Text] [Related]
3. Extended rhodamine photosensitizers for photodynamic therapy of cancer cells.
Davies KS; Linder MK; Kryman MW; Detty MR
Bioorg Med Chem; 2016 Sep; 24(17):3908-3917. PubMed ID: 27246858
[TBL] [Abstract][Full Text] [Related]
4. Selective photodepletion of malignant T cells in extracorporeal photopheresis with selenorhodamine photosensitizers.
McIver ZA; Kryman MW; Choi Y; Coe BN; Schamerhorn GA; Linder MK; Davies KS; Hill JE; Sawada GA; Grayson JM; Detty MR
Bioorg Med Chem; 2016 Sep; 24(17):3918-3931. PubMed ID: 27301678
[TBL] [Abstract][Full Text] [Related]
5. Thiorhodamines containing amide and thioamide functionality as inhibitors of the ATP-binding cassette drug transporter P-glycoprotein (ABCB1).
Orchard A; Schamerhorn GA; Calitree BD; Sawada GA; Loo TW; Claire Bartlett M; Clarke DM; Detty MR
Bioorg Med Chem; 2012 Jul; 20(14):4290-302. PubMed ID: 22727780
[TBL] [Abstract][Full Text] [Related]
6. In vitro demonstration of the heavy-atom effect for photodynamic therapy.
Gorman A; Killoran J; O'Shea C; Kenna T; Gallagher WM; O'Shea DF
J Am Chem Soc; 2004 Sep; 126(34):10619-31. PubMed ID: 15327320
[TBL] [Abstract][Full Text] [Related]
7. A selenopyrylium photosensitizer for photodynamic therapy related in structure to the antitumor agent AA1 with potent in vivo activity and no long-term skin photosensitization.
Leonard KA; Hall JP; Nelen MI; Davies SR; Gollnick SO; Camacho S; Oseroff AR; Gibson SL; Hilf R; Detty MR
J Med Chem; 2000 Nov; 43(23):4488-98. PubMed ID: 11087573
[TBL] [Abstract][Full Text] [Related]
8. Rhodamine inhibitors of P-glycoprotein: an amide/thioamide "switch" for ATPase activity.
Gannon MK; Holt JJ; Bennett SM; Wetzel BR; Loo TW; Bartlett MC; Clarke DM; Sawada GA; Higgins JW; Tombline G; Raub TJ; Detty MR
J Med Chem; 2009 May; 52(10):3328-41. PubMed ID: 19402665
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological evaluation of 17
Zhu W; Wang LX; Chen DY; Gao YH; Yan YJ; Wu XF; Wang M; Han YP; Chen ZL
Bioorg Med Chem Lett; 2018 Sep; 28(16):2784-2788. PubMed ID: 29279274
[TBL] [Abstract][Full Text] [Related]
10. Oligolysine-conjugated zinc(II) phthalocyanines as efficient photosensitizers for antimicrobial photodynamic therapy.
Ke MR; Eastel JM; Ngai KL; Cheung YY; Chan PK; Hui M; Ng DK; Lo PC
Chem Asian J; 2014 Jul; 9(7):1868-75. PubMed ID: 24799418
[TBL] [Abstract][Full Text] [Related]
11. Dicyanomethylene Substituted Benzothiazole Squaraines: The Efficiency of Photodynamic Therapy In Vitro and In Vivo.
Wei Y; Hu X; Shen L; Jin B; Liu X; Tan W; Shangguan D
EBioMedicine; 2017 Sep; 23():25-33. PubMed ID: 28811165
[TBL] [Abstract][Full Text] [Related]
12. Antiproliferative effect of pheophorbide a-mediated photodynamic therapy and its synergistic effect with doxorubicin on multiple drug-resistant uterine sarcoma cell MES-SA/Dx5.
Cheung KK; Chan JY; Fung KP
Drug Chem Toxicol; 2013 Oct; 36(4):474-83. PubMed ID: 23560455
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and in vitro photocytotoxicity of coumarin derivatives for one- and two-photon excited photodynamic therapy.
Zou Q; Fang Y; Zhao Y; Zhao H; Wang Y; Gu Y; Wu F
J Med Chem; 2013 Jul; 56(13):5288-94. PubMed ID: 23763331
[TBL] [Abstract][Full Text] [Related]
14. Mitochondria-Targeting Selenophene-Modified BODIPY-Based Photosensitizers for the Treatment of Hypoxic Cancer Cells.
Karaman O; Almammadov T; Emre Gedik M; Gunaydin G; Kolemen S; Gunbas G
ChemMedChem; 2019 Nov; 14(22):1879-1886. PubMed ID: 31663667
[TBL] [Abstract][Full Text] [Related]
15. ABCG2-mediated transport of photosensitizers: potential impact on photodynamic therapy.
Robey RW; Steadman K; Polgar O; Bates SE
Cancer Biol Ther; 2005 Feb; 4(2):187-94. PubMed ID: 15684613
[TBL] [Abstract][Full Text] [Related]
16. (R)-[(11)C]verapamil is selectively transported by murine and human P-glycoprotein at the blood-brain barrier, and not by MRP1 and BCRP.
Römermann K; Wanek T; Bankstahl M; Bankstahl JP; Fedrowitz M; Müller M; Löscher W; Kuntner C; Langer O
Nucl Med Biol; 2013 Oct; 40(7):873-8. PubMed ID: 23845421
[TBL] [Abstract][Full Text] [Related]
17. New BODIPYs for photodynamic therapy (PDT): Synthesis and activity on human cancer cell lines.
Caruso E; Malacarne MC; Marras E; Papa E; Bertato L; Banfi S; Gariboldi MB
Bioorg Med Chem; 2020 Nov; 28(21):115737. PubMed ID: 33065434
[TBL] [Abstract][Full Text] [Related]
18. Tumor microenvironment-activated nanosystems with selenophenol substituted BODIPYs as photosensitizers for photodynamic therapy.
Gao W; Li M; Xu G; Wang R; Shi B; Zhu T; Gao J; Gu X; Shi P; Zhao C
Bioorg Med Chem Lett; 2020 Jan; 30(2):126854. PubMed ID: 31859157
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and characterization of novel purpurinimides as photosensitizers for photodynamic therapy.
Cui BC; Yoon I; Li JZ; Lee WK; Shim YK
Int J Mol Sci; 2014 May; 15(5):8091-105. PubMed ID: 24815070
[TBL] [Abstract][Full Text] [Related]
20. P-glycoprotein-targeted photodynamic therapy boosts cancer nanomedicine by priming tumor microenvironment.
Mao C; Li F; Zhao Y; Debinski W; Ming X
Theranostics; 2018; 8(22):6274-6290. PubMed ID: 30613297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
